Risk of colonic neoplasia after liver transplantation for primary sclerosing cholangitis
β Scribed by Ibrahim A. Hanouneh; Carole Macaron; Rocio Lopez; Nizar N. Zein; Bret A. Lashner
- Book ID
- 112101140
- Publisher
- John Wiley and Sons
- Year
- 2012
- Tongue
- English
- Weight
- 169 KB
- Volume
- 18
- Category
- Article
- ISSN
- 1078-0998
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Liver transplantation (LT) is the only therapeutic option for end-stage primary sclerosing cholangitis (PSC), but PSC can recur (rPSC) in some patients after LT. The aim of our study was to evaluate the risk factors associated with rPSC. Between 1989 and 2004, 69 patients receiving transplantation f
Orthotopic liver transplantation (OLT) is the only effective treatment for end-stage liver disease due to primary sclerosing cholangitis (PSC). Recurrence of PSC has recently emerged as a leading cause of allograft failure in the long term. There is limited data on risk factors for recurrence of PSC